{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:28:44Z","timestamp":1783456124959,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jcyt.2020.08.013","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T08:14:01Z","timestamp":1602317641000},"page":"203-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Julie","family":"Brault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Meis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezekiel","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry M.","family":"Koontz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennichi","family":"Dowdell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narda","family":"Theobald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornell","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron B.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Ravell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Lenardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry L.","family":"Malech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk See","family":"De Ravin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.jcyt.2020.08.013_bib0001","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1182\/blood-2013-11-538686","article-title":"XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus","volume":"123","author":"Li","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jcyt.2020.08.013_bib0002","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/MOP.0000000000000156","article-title":"X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia disease: a combined immune deficiency with magnesium defect","volume":"26","author":"Ravell","year":"2014","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"10.1016\/j.jcyt.2020.08.013_bib0003","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1684\/mrh.2015.0381","article-title":"The role of MAGT1 in genetic syndromes","volume":"28","author":"Trapani","year":"2015","journal-title":"Magnes Res"},{"issue":"1","key":"10.1016\/j.jcyt.2020.08.013_bib0004","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10875-016-0341-y","article-title":"Large Deletion of MAGT1 Gene in a Patient with Classic Kaposi Sarcoma, CD4 Lymphopenia, and EBV Infection","volume":"37","author":"Brigida","year":"2017","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.jcyt.2020.08.013_bib0005","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10875-014-0116-2","article-title":"Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease","volume":"35","author":"Dhalla","year":"2015","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.jcyt.2020.08.013_bib0006","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.clim.2015.04.015","article-title":"A case of XMEN syndrome presented with severe auto-immune disorders mimicking autoimmune lymphoproliferative disease","volume":"159","author":"Patiroglu","year":"2015","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.jcyt.2020.08.013_bib0007","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10875-020-00746-1","article-title":"The Many Faces of XMEN Disease, Report of Two Patients with Novel Mutations","volume":"40","author":"Hoyos-Bachiloglu","year":"2020","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.jcyt.2020.08.013_bib0008","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10875-019-00732-2","article-title":"Diversity of XMEN Disease: Description of 2 Novel Variants and Analysis of the Lymphocyte Phenotype","volume":"40","author":"Klinken","year":"2020","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.jcyt.2020.08.013_bib0009","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1172\/JCI131116","article-title":"Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease","volume":"130","author":"Ravell","year":"2020","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.jcyt.2020.08.013_bib0010","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10875-020-00790-x","article-title":"An Update on XMEN Disease","volume":"40","author":"Ravell","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jcyt.2020.08.013_bib0011","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2164-6-48","article-title":"Identification and characterization of a novel mammalian Mg2+ transporter with channel-like properties","volume":"6","author":"Goytain","year":"2005","journal-title":"BMC Genomics"},{"issue":"37","key":"10.1016\/j.jcyt.2020.08.013_bib0012","doi-asserted-by":"crossref","first-page":"15750","DOI":"10.1073\/pnas.0908332106","article-title":"Mammalian MagT1 and TUSC3 are required for cellular magnesium uptake and vertebrate embryonic development","volume":"106","author":"Zhou","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.jcyt.2020.08.013_bib0013","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1083\/jcb.201404083","article-title":"Oxidoreductase activity is necessary for N-glycosylation of cysteine-proximal acceptor sites in glycoproteins","volume":"206","author":"Cherepanova","year":"2014","journal-title":"J Cell Biol"},{"issue":"37","key":"10.1016\/j.jcyt.2020.08.013_bib0014","doi-asserted-by":"crossref","first-page":"13638","DOI":"10.1074\/jbc.RA119.008903","article-title":"Magnesium transporter 1 (MAGT1) deficiency causes selective defects in N-linked glycosylation and expression of immune-response genes","volume":"294","author":"Matsuda-Lennikov","year":"2019","journal-title":"J Biol Chem"},{"issue":"20","key":"10.1016\/j.jcyt.2020.08.013_bib0015","doi-asserted-by":"crossref","first-page":"9865","DOI":"10.1073\/pnas.1817815116","article-title":"Mutations in MAGT1 lead to a glycosylation disorder with a variable phenotype","volume":"116","author":"Blommaert","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6142","key":"10.1016\/j.jcyt.2020.08.013_bib0017","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1126\/science.1240094","article-title":"Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D","volume":"341","author":"Chaigne-Delalande","year":"2013","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.jcyt.2020.08.013_bib0018","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.semcancer.2006.07.008","article-title":"The role of the NKG2D receptor for tumor immunity","volume":"16","author":"Coudert","year":"2006","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10.1016\/j.jcyt.2020.08.013_bib0019","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5114\/ceji.2015.56168","article-title":"Combined immunodeficiencies: twenty years\u2019 experience from a single center in Turkey","volume":"41","author":"Akar","year":"2016","journal-title":"Cent Eur J Immunol"},{"issue":"1","key":"10.1016\/j.jcyt.2020.08.013_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-018-0573-0","article-title":"Successful Bone Marrow Transplantation for XMEN: Hemorrhagic Risk Uncovered","volume":"39","author":"Dimitrova","year":"2019","journal-title":"J Clin Immunol"},{"issue":"8941","key":"10.1016\/j.jcyt.2020.08.013_bib0021","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","article-title":"Use of Gene-Modified Virus-Specific T-Lymphocytes to Control Epstein-Barr-Virus-Related Lymphoproliferation","volume":"345","author":"Rooney","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jcyt.2020.08.013_bib0022","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/14653249.2011.636963","article-title":"Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant","volume":"14","author":"Sili","year":"2012","journal-title":"Cytotherapy"},{"issue":"11","key":"10.1016\/j.jcyt.2020.08.013_bib0023","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1182\/blood-2011-08-371971","article-title":"Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation","volume":"119","author":"Doubrovina","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jcyt.2020.08.013_bib0024","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcyt.2020.08.013_bib0025","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.biomaterials.2017.11.034","article-title":"Emergence of synthetic mRNA: in vitro synthesis of mRNA and its applications in regenerative medicine","volume":"156","author":"Kwon","year":"2018","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.jcyt.2020.08.013_bib0026","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"MRNA vaccines\u2014a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"10.1016\/j.jcyt.2020.08.013_bib0027","doi-asserted-by":"crossref","first-page":"E1941","DOI":"10.1073\/pnas.1619653114","article-title":"Systemic delivery of factor IX messenger RNA for protein replacement therapy","volume":"114","author":"Ramaswamy","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.jcyt.2020.08.013_bib0028","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"MRNA-based therapeutics\u2014developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nature Reviews Drug Discovery"},{"issue":"4","key":"10.1016\/j.jcyt.2020.08.013_bib0029","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/mt.2012.31","article-title":"MRNA Leapfrogs DNA to Show Promise for Therapeutic Gene Transfer","volume":"20","author":"Gilboa","year":"2012","journal-title":"Molecular Therapy"},{"issue":"21","key":"10.1016\/j.jcyt.2020.08.013_bib0030","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1093\/nar\/gkr695","article-title":"Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA","volume":"39","author":"Kariko","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.jcyt.2020.08.013_bib0031","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood.V98.1.49","article-title":"Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells","volume":"98","author":"Van Tendeloo","year":"2001","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jcyt.2020.08.013_bib0032","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/sj.leu.2405007","article-title":"Efficient gene transfer in CLL by mRNA electroporation","volume":"22","author":"Van Bockstaele","year":"2008","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.jcyt.2020.08.013_bib0033","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2010.01.030","article-title":"Flow-through electroporation based on constant voltage for large-volume transfection of cells","volume":"144","author":"Geng","year":"2010","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.jcyt.2020.08.013_bib0034","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/cgt.2009.61","article-title":"Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral method","volume":"17","author":"Li","year":"2010","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.jcyt.2020.08.013_bib0035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1182\/asheducation-2013.1.234","article-title":"Bringing natural killer cells to the clinic: ex vivo manipulation","volume":"2013","author":"Childs","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jcyt.2020.08.013_bib0036","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fimmu.2016.00105","article-title":"Efficient mRNA-Based Genetic Engineering of Human NK Cells with High-Affinity CD16 and CCR7 Augments Rituximab-Induced ADCC against Lymphoma and Targets NK Cell Migration toward the Lymph Node-Associated Chemokine CCL19","volume":"7","author":"Carlsten","year":"2016","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.jcyt.2020.08.013_bib0037","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-08-3712","article-title":"Expansion of highly cytotoxic human natural killer cells for cancer cell therapy","volume":"69","author":"Fujisaki","year":"2009","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.jcyt.2020.08.013_bib0038","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1158\/2326-6066.CIR-15-0229","article-title":"Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma","volume":"4","author":"Kamiya","year":"2016","journal-title":"Cancer Immunol Res"},{"issue":"7357","key":"10.1016\/j.jcyt.2020.08.013_bib0039","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature10246","article-title":"Second messenger role for Mg2+ revealed by human T-cell immunodeficiency","volume":"475","author":"Li","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2020.08.013_bib0040","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3389\/fimmu.2019.02000","article-title":"Magnesium Restores Activity to Peripheral Blood Cells in a Patient With Functionally Impaired Interleukin-2-Inducible T Cell Kinase","volume":"10","author":"Howe","year":"2019","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.jcyt.2020.08.013_bib0041","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/1097-0320(20001201)41:4<289::AID-CYTO7>3.0.CO;2-5","article-title":"Design of a flow cytometric assay for the determination of natural killer and cytotoxic T-lymphocyte activity in human and in different animal species","volume":"41","author":"Piriou","year":"2000","journal-title":"Cytometry"},{"key":"10.1016\/j.jcyt.2020.08.013_bib0042","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.omtn.2019.08.001","article-title":"Expression Kinetics and Innate Immune Response after Electroporation and LNP-Mediated Delivery of a Self-Amplifying mRNA in the Skin","volume":"17","author":"Huysmans","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1016\/j.jcyt.2020.08.013_bib0043","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1074-7613(02)00333-3","article-title":"The role of the NKG2D immunoreceptor in immune cell activation and natural killing","volume":"17","author":"Jamieson","year":"2002","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.jcyt.2020.08.013_bib0044","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2003-06-2125","article-title":"Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells","volume":"103","author":"Verneris","year":"2004","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.jcyt.2020.08.013_bib0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/hon.2591","article-title":"CAR T-cell therapy: Full speed ahead","volume":"37","author":"Sermer","year":"2019","journal-title":"Hematol Oncol"},{"issue":"2","key":"10.1016\/j.jcyt.2020.08.013_bib0046","doi-asserted-by":"crossref","first-page":"175S","DOI":"10.1042\/bst025175s","article-title":"Natural killer cell function is altered by freezing in DMSO","volume":"25","author":"Dominguez","year":"1997","journal-title":"Biochem Soc Trans"},{"issue":"12","key":"10.1016\/j.jcyt.2020.08.013_bib0047","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1007\/s00432-016-2247-8","article-title":"Cryopreserved NK cells in the treatment of haematological malignancies: preclinical study","volume":"142","author":"Holubova","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"10.1016\/j.jcyt.2020.08.013_bib0048","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.4110\/in.2018.18.e31","article-title":"Optimization of Large-Scale Expansion and Cryopreservation of Human Natural Killer Cells for Anti-Tumor Therapy","volume":"18","author":"Min","year":"2018","journal-title":"Immune Netw"},{"issue":"3","key":"10.1016\/j.jcyt.2020.08.013_bib0049","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/14653240902807034","article-title":"Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells","volume":"11","author":"Berg","year":"2009","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.jcyt.2020.08.013_bib0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.drudis.2015.07.009","article-title":"Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger","volume":"21","author":"Devoldere","year":"2016","journal-title":"Drug Discov Today"},{"issue":"10","key":"10.1016\/j.jcyt.2020.08.013_bib0051","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/j.ymthe.2018.06.002","article-title":"Global Transcriptional Response to CRISPR\/Cas9-AAV6-Based Genome Editing in CD34(+) Hematopoietic Stem and Progenitor Cells","volume":"26","author":"Cromer","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcyt.2020.08.013_bib0052","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-1-4939-6481-9_10","article-title":"Electroporation of mRNA as Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins","volume":"1499","author":"Gerer","year":"2017","journal-title":"Rna Vaccines: Methods and Protocols"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324920308525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324920308525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:42:44Z","timestamp":1761442964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324920308525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1465324920308525"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2020.08.013","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia disease","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2020.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of International Society for Cell &#38; Gene Therapy.","name":"copyright","label":"Copyright"}]}}